News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current LSL market cap is 10.32M. The company's latest EPS is CAD -0.0036 and P/E is -138.89.
| Year End July 30 2022 | 2022 |
|---|---|
| CAD ($) | |
| Total Revenue | 0 |
| Operating Income | -3k |
| Net Income | -74k |
| Year End July 30 2022 | 2022 |
|---|---|
| CAD ($) | |
| Total Assets | 25k |
| Total Liabilities | 285k |
| Total Equity | -260k |
| Year End July 30 2022 | 2022 |
|---|---|
| CAD ($) | |
| Operating | -3k |
| Investing | N/A |
| Financing | 3k |
| Market Cap | 10.32M |
| Price to Earnings Ratio | -138.89 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | -39.7 |
| Dividend Yield | - |
| Shares Outstanding | 20.65M |
| Average Volume (1 week) | 9.87k |
| Average Volume (1 Month) | 19.69k |
| 52 Week Change | -1.96% |
| 52 Week High | 0.57 |
| 52 Week Low | 0.35 |
| Spread (Intraday) | 0.02 (4%) |
| Company Name | LSL Pharma Group Inc |
| Address |
3030, boul. le carrefour, bureau 1002, laval qu��bec H7T 2P5 |
| Website | https://www.lsl-pharma.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
